Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cusan

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Urology|October 1, 1991
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostateA Dupont, L Cusan, J L Gomez, et al.
British Journal of Urology|November 1, 1993
Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinomaA Dupont, L Cusan, J L Gomez, et al.
The Prostate|May 1, 1994
Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamideL Cusan, J L Gomez, A Dupont, et al.
Urology|February 1, 1996
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigenF Labrie, B Candas, L Cusan, et al.
Endocrinology|May 1, 1979
Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female ratsL Cusan, C Auclair, A Belanger, et al.
Nature|August 11, 1977
Potent prolactin and growth hormone releasing activity of more analogues of Met-enkephalinL Cusan, A Dupont, G S Kledzik, et al.
The Journal of Urology|March 1, 1992
Serum prostate specific antigen as pre-screening test for prostate cancerF Labrie, A Dupont, R Suburu, et al.
The American Journal of Medicine|May 1, 1992
Incidence of liver toxicity associated with the use of flutamide in prostate cancer patientsJ L Gomez, A Dupont, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old menA Bélanger, B Candas, A Dupont, et al.
Nature Medicine|February 1, 1995
The impact of family history on early detection of prostate cancerS A Narod, A Dupont, L Cusan, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Urology|October 1, 1991
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostateA Dupont, L Cusan, J L Gomez, et al.
British Journal of Urology|November 1, 1993
Combination therapy with flutamide and the LHRH agonist [D-Trp6, des-Gly-NH(2)10]LHRH ethylamide in stage C prostatic carcinomaA Dupont, L Cusan, J L Gomez, et al.
The Prostate|May 1, 1994
Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamideL Cusan, J L Gomez, A Dupont, et al.
Urology|February 1, 1996
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigenF Labrie, B Candas, L Cusan, et al.
Endocrinology|May 1, 1979
Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female ratsL Cusan, C Auclair, A Belanger, et al.
Nature|August 11, 1977
Potent prolactin and growth hormone releasing activity of more analogues of Met-enkephalinL Cusan, A Dupont, G S Kledzik, et al.
The Journal of Urology|March 1, 1992
Serum prostate specific antigen as pre-screening test for prostate cancerF Labrie, A Dupont, R Suburu, et al.
The American Journal of Medicine|May 1, 1992
Incidence of liver toxicity associated with the use of flutamide in prostate cancer patientsJ L Gomez, A Dupont, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old menA Bélanger, B Candas, A Dupont, et al.
Nature Medicine|February 1, 1995
The impact of family history on early detection of prostate cancerS A Narod, A Dupont, L Cusan, et al.
Pageof 10